Search research articles
Contact Us
Filters
Showing results (81-90 of 136) with videos related to
Page
of 14
Sort By:
Endocrinology
|
April 19, 2017
The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice
Rachel J Fenske, Mark T Cadena, Quincy E Harenda, et al.
Cancer Medicine
|
April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
Cancers
|
May 14, 2025
Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8<sup>+</sup> T Cells in Breast Cancer
Philip B Emmerich, Tonela Qyli, Katherine A Johnson, et al.
Nucleic Acids Research
|
December 5, 2021
BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity
Eui-Jun Kim, Peng Liu, Shengjie Zhang, et al.
NPJ Precision Oncology
|
October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapy
Hamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Nature Cancer
|
October 29, 2021
Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy
Jason I Griffiths, Jinfeng Chen, Patrick A Cosgrove, et al.
Cancer Research Communications
|
October 17, 2025
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)
Mamta Parikh, Nataliya V Uboha, Naoko Takebe, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer
Sasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Molecular Cancer Therapeutics
|
September 29, 2021
Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer
Yang Hu, Baraa K Manasrah, Stephanie M McGregor, et al.
Cancer Discovery
|
January 27, 2016
Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression
Madeleine J Oudin, Oliver Jonas, Tatsiana Kosciuk, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 136) with videos related to
Sort By:
Page
of 14
Endocrinology
|
April 19, 2017
The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice
Rachel J Fenske, Mark T Cadena, Quincy E Harenda, et al.
Cancer Medicine
|
April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
Cancers
|
May 14, 2025
Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8<sup>+</sup> T Cells in Breast Cancer
Philip B Emmerich, Tonela Qyli, Katherine A Johnson, et al.
Nucleic Acids Research
|
December 5, 2021
BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity
Eui-Jun Kim, Peng Liu, Shengjie Zhang, et al.
NPJ Precision Oncology
|
October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapy
Hamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Nature Cancer
|
October 29, 2021
Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy
Jason I Griffiths, Jinfeng Chen, Patrick A Cosgrove, et al.
Cancer Research Communications
|
October 17, 2025
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)
Mamta Parikh, Nataliya V Uboha, Naoko Takebe, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer
Sasha E Stanton, Denise L Cecil, Howard H Bailey, et al.
Molecular Cancer Therapeutics
|
September 29, 2021
Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer
Yang Hu, Baraa K Manasrah, Stephanie M McGregor, et al.
Cancer Discovery
|
January 27, 2016
Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression
Madeleine J Oudin, Oliver Jonas, Tatsiana Kosciuk, et al.
Page
of 14